SEC Filing Details
Document Details
Form
Filing Date
Jul 10, 2020
Document Date
Jan 7, 2020
Form Description
Amendment to a previously filed 4
Filing Group
3,4,5
Company
Akero Therapeutics, Inc.
Issuer
Akero Therapeutics, Inc.
Filer
Versant Venture Capital VI, L.P.